In the BioHarmony Drug Report Database

"Preview" Icon

Nifedipine

Adalat, Adalat Cc, Procardia, Procardia Xl (nifedipine) is a small molecule pharmaceutical. Nifedipine was first approved as Adalat on 1982-01-01. It is used to treat hypertension, stable angina, and variant angina pectoris in the USA. It is known to target glycine receptor subunit beta, voltage-dependent L-type calcium channel subunit alpha-1C, voltage-dependent L-type calcium channel subunit alpha-1S, transient receptor potential cation channel subfamily M member 3, glycine receptor subunit alpha-3, glycine receptor subunit alpha-1, voltage-dependent L-type calcium channel subunit alpha-1D, voltage-dependent L-type calcium channel subunit alpha-1F, nuclear receptor subfamily 1 group I member 2, potassium voltage-gated channel subfamily A member 5, potassium voltage-gated channel subfamily C member 1, potassium voltage-gated channel subfamily A member 7, potassium voltage-gated channel subfamily A member 2, and potassium voltage-gated channel subfamily A member 1.

 

Trade Name

 

Adalat, Adalat Cc, Procardia, Procardia Xl
 

Common Name

 

nifedipine
 

ChEMBL ID

 

CHEMBL193
 

Indication

 

hypertension, stable angina, variant angina pectoris
 

Drug Class

 

Phenylpyridine vasodilators (nifedipine type)

Image (chem structure or protein)

Nifedipine structure rendering